Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Desmoglein 3 Protein (DSG3) (AA 50-617) (His tag)

DSG3 Origine: Souris Hôte: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
N° du produit ABIN7274503
  • Antigène Voir toutes Desmoglein 3 (DSG3) Protéines
    Desmoglein 3 (DSG3)
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 50-617
    Origine
    • 7
    • 3
    Souris
    Source
    • 6
    • 3
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette Desmoglein 3 protéine est marqué à la His tag.
    Fonction
    Mouse DSG3 Protein
    Séquence
    Glu50-Pro617
    Attributs du produit
    Recombinant Mouse DSG3 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Glu50-Pro617.
    Pureté
    > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
    Stérilité
    0.22 μm filtered
    niveau d'endotoxine
    Less than 1EU per μg by the LAL method.
    Top Product
    Discover our top product DSG3 Protéine
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
    Buffer
    Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    Desmoglein 3 (DSG3)
    Autre désignation
    DSG3 (DSG3 Produits)
    Synonymes
    DSG3 Protein, CDHF6 Protein, PVA Protein, bal Protein, balding Protein, desmoglein 3 Protein, DSG3 Protein, Dsg3 Protein
    Sujet
    To identify genes that could potentially serve as molecular therapeutic markers for human head and neck cancer (HNC),DSG3 is identified overexpressed in HNC, with the degree of overexpression associated with clinicopathologic features of the tumor. Inhibition of DSG3 significantly suppresses carcinogenic potential in cellular and in vivo animal studies. DSG3 is a potential molecular target in the development of adjuvant therapy for HNC.
    Poids moléculaire
    64.3 kDa. Due to glycosylation, the protein migrates to 70-75 kDa based on Tris-Bis PAGE result.
Vous êtes ici: